HOLLO Medical has developed a compact inhaler accessory that enhances medication delivery by replacing traditional valved holding chambers. This device addresses the issues of bulkiness and inefficiency in current inhalation systems, improving user experience and medication adherence.
Funding
$310K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IFounders
Product
Problem
Current valved holding chambers (VHCs) for inhalers are often bulky, inconvenient, and can be embarrassing for users, leading to poor adherence to prescribed medication regimens. These traditional chambers can also be inefficient in delivering medication to the lungs, reducing the therapeutic benefit of inhalers.
Solution
Hollo Medical is developing a compact inhaler accessory that aims to replace traditional VHCs, enhancing medication delivery and improving the user experience. The device is designed to be discreet, efficient, and easy to use, fitting comfortably in a pocket while ensuring more medication reaches the lungs. By addressing the limitations of existing holding chambers, Hollo Medical seeks to reduce the burden of chronic respiratory diseases and improve patient outcomes. The company's mission is to enable patients to focus on their lives, rather than being held back by cumbersome medical devices.
Target Audience
The primary target audience includes individuals with chronic respiratory diseases, such as asthma and COPD, who use inhalers and require a more convenient and effective holding chamber solution.
Features
- Compact and discreet design for improved portability and user comfort
- Enhanced medication delivery to the lungs compared to traditional VHCs
- Easy-to-use interface for improved patient adherence